FDA Budget Limits Mean Personnel Cuts Likely; 15% Reduction in Admin
Executive Summary
The Center for Drug Evaluation & Research will likely cut administrative and information technology personnel to meet fiscal year 2004 budget constraints, Director Janet Woodcock, MD, says
You may also be interested in...
AHRQ Comparative Trial Funding Awaits Supplemental Appropriation
The comparative trial/cost effectiveness provisions in the Medicare legislation will require a supplemental appropriation for the Agency for Healthcare Research & Quality
FDA Drug Safety Upgrades Coming; Medicare Bill Could Help Win Funding
The Medicare prescription drug coverage legislation should help FDA make the case for additional funding for post-marketing surveillance, according to Center for Drug Evaluation & Research Acting Director Steven Galson, MD
CDER Deputy Galson Will Run Drug Center For At Least Six Months
Center for Drug Evaluation & Research Deputy Director Steve Galson, MD, will be acting center director during the period when FDA is expected to announce a decision on forced Rx-to-OTC switches